No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents / pharmacology*
-
Aurora Kinases
-
Benzamides
-
Benzimidazoles / pharmacology*
-
Cell Line, Tumor
-
Cell Survival / drug effects
-
Cells, Cultured
-
Humans
-
Imatinib Mesylate
-
Janus Kinases / antagonists & inhibitors*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / enzymology*
-
Piperazines / pharmacology*
-
Protein Kinase Inhibitors / pharmacology*
-
Protein Serine-Threonine Kinases / antagonists & inhibitors
-
Pyrimidines / pharmacology*
-
Urea / analogs & derivatives*
-
Urea / pharmacology
Substances
-
1-cyclopropyl-3-(3-(5-morpholin-4-ylmethyl-1H-benzoimidazol-2-yl)-1H-pyrazol-4-yl)urea
-
Antineoplastic Agents
-
Benzamides
-
Benzimidazoles
-
Piperazines
-
Protein Kinase Inhibitors
-
Pyrimidines
-
Imatinib Mesylate
-
Urea
-
Janus Kinases
-
Aurora Kinases
-
Protein Serine-Threonine Kinases